IFITM3 and hepatocellular carcinoma: Immunohistochemical analysis demonstrated high expression of IFITM3 protein in 64.1% (82 of 128) of HCC tissue samples and 22.7% (29 of 128) of the adjacent normal tissues (Fig. 1B).